Detalhe da pesquisa
1.
Pharmacologic modulation of RNA splicing enhances anti-tumor immunity.
Cell
; 184(15): 4032-4047.e31, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171309
2.
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia.
Nat Cancer
; 3(7): 837-851, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35668193
3.
Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer.
Nat Genet
; 52(4): 408-417, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32203462
4.
Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity.
Cell Metab
; 29(5): 1217-1231.e7, 2019 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30773463
5.
Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia.
Sci Rep
; 6: 27696, 2016 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27283158